Plain language summary of Pfizer-BioNTech BNT162b2 COVID-19 vaccine safety in participants 16 years or older and protection against COVID-19 in participants 12 years or older

This new plain language summary in Future Virology looks at the latest findings on the role of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine.

Read the full article here.

The original article on which this summary is based is called ‘Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months’ and was originally published in the journal The New England Journal of Medicine. The original article can be read here.

• vaccine
• vaccine development
• vaccine efficacy
• vaccine safety